Communication Regarding Organ and Tissue Donation in Intensive Care (COMFORT)

October 3, 2017 updated by: NSW Organ and Tissue Donation Service

Communication With Families Regarding Organ and Tissue Donation After Death in Intensive Care Study

The overarching aim of this study is to examine the process of organ donation decision-making and to determine whether changes in requesting practices change rates of consent for donation, and other family-based outcomes.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

417

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New South Wales
      • New Lambton Heights, New South Wales, Australia, 2305
        • John Hunter Hospital
      • Sydney, New South Wales, Australia, 2145
        • The Children's Hospital at Westmead
      • Sydney, New South Wales, Australia, 2065
        • Royal North Shore Hospital
      • Sydney, New South Wales, Australia, 2010
        • St Vincent's Hospital
      • Sydney, New South Wales, Australia, 2031
        • Prince of Wales Hospital
      • Sydney, New South Wales, Australia, 2217
        • St George Hospital
      • Sydney, New South Wales, Australia, 1871
        • Liverpool Hospital
      • Sydney, New South Wales, Australia, 2052
        • Royal Prince Alfred Hospital
      • Sydney, New South Wales, Australia, 2217
        • NSW Organ and Tissue Donation Service
      • Tweed Heads, New South Wales, Australia, 2485
        • The Tweed Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Donation events identified by a patient who is a potential organ and tissue donor in a participating ICU or under the care of ICU health professionals.
  • For the primary endpoint only, patients must not have registered their donation wishes.

Exclusion Criteria:

  • A patient who is not medically suitable for organ or tissue donation.
  • A patient who does not have next of kin available to participate in donation conversations.
  • A patient in the ICU who is able to provide first person consent for deceased donation, for example a patient with spinal injuries.
  • A patient who is suitable to donate only tissue after death.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Communication intervention
This study uses a single arm design with current 'controls' to explore an intervention, the procedure for providing information and requesting consent for donation, that uses new agreed best practice procedures led by specially trained intensive care health professionals. The study intervention is a staff education and training module intended to provide a framework and preparation for select critical care staff to conduct organ donation discussions in line with best practice.

The intervention is a modification of current standard practice procedures for requesting consent for donation.

The intervention period commences when the possibility of organ donation is first raised with the family, and includes the time for families to make a decision. This time may last up to 72 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of families providing consent for deceased organ donation.
Time Frame: Up to 72 hours subsequent to raising deceased donation with next of kin.
Final decision of either written or verbal consent or decline to deceased organ donation provided at the hospital.
Up to 72 hours subsequent to raising deceased donation with next of kin.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of senior next of kin who report they regretted their final decision either to consent or to decline donation.
Time Frame: 90 days post enrollment.
This outcome will be assesed using a telephone follow-up call.
90 days post enrollment.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health professionals' adherence rates to core elements of the intervention.
Time Frame: Up to 72 hours subsequent to next of kin making their final donation decision.
This will be measured by observation and self-report at the hospital.
Up to 72 hours subsequent to next of kin making their final donation decision.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert Herkes, NSW Organ and Tissue Donation Service

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2013

Primary Completion (Actual)

July 8, 2016

Study Completion (Actual)

December 21, 2016

Study Registration Dates

First Submitted

August 10, 2013

First Submitted That Met QC Criteria

August 12, 2013

First Posted (Estimate)

August 14, 2013

Study Record Updates

Last Update Posted (Actual)

October 5, 2017

Last Update Submitted That Met QC Criteria

October 3, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • DR-01-2012
  • ACTRN12613000815763 (Registry Identifier: Australian New Zealand Clinical Trials Registry (ANZCTR))

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tissue and Organ Procurement

Clinical Trials on Communication intervention

Subscribe